QuidelOrtho Corp (QDEL)
2025-06-29 | 2025-03-30 | 2024-09-29 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 613,900 | 692,800 | 727,100 | 637,000 |
| Research and development | 45,700 | 53,200 | 55,900 | 56,300 |
| Other operating expenses | 5,100 | 6,400 | 6,300 | 9,300 |
| Asset impairment charge | - | - | - | 56,900 |
| Goodwill impairment charge | - | - | - | - |
| Cost of sales, excluding amortization of intangibles | 339,000 | 349,500 | 374,800 | 361,000 |
| Amortization of intangible assets | 47,900 | 48,000 | 51,900 | 51,900 |
| Restructuring, integration and other charges | 178,900 | - | - | - |
| Selling, marketing and administrative | 178,000 | 187,000 | 186,400 | 188,200 |
| Integration related costs | - | 16,100 | 36,800 | 30,900 |
| Operating loss | -180,700 | 32,600 | 15,000 | -117,500 |
| Interest expense, net | 40,500 | 40,000 | - | - |
| Other expense, net | -8,400 | -1,400 | -900 | -4,400 |
| Interest expense, net | - | - | -42,900 | -41,000 |
| Loss before income taxes | -229,600 | -8,800 | -28,800 | -162,900 |
| Provision for (benefit from) income taxes | 25,800 | 3,900 | -8,900 | -15,200 |
| Net loss | -255,400 | -12,700 | -19,900 | -147,700 |
| Basic loss per share | -3.77 | -0.19 | -0.3 | -2.2 |
| Diluted loss per share | -3.77 | -0.19 | -0.3 | -2.2 |
| Weighted-average shares outstanding - basic | 67,700,000 | 67,500,000 | 67,300,000 | 67,100,000 |
| Weighted-average shares outstanding - diluted | 67,700,000 | 67,500,000 | 67,300,000 | 67,100,000 |